Parasitic Infection Drug Prior Authorization Request Form Coverage Criteria
A prescriber-completed prior authorization request form for outpatient pharmacy coverage of drugs used to treat parasitic infections; collects beneficiary, prescriber, drug, therapy duration, and a single clinical question about treatment for a parasitic infection. Affects prescribers and pharmacy benefit administrators.
No material clinical or coverage changes in this revision.
Coverage Criteria
No specific coverage exclusions are stated on the prior authorization form. The document contains a single clinical question about whether the beneficiary is being treated for a parasitic infection but does not enumerate any conditions or situations that would render treatment ineligible or explicitly excluded.
The form does not define circumstances that would make the requested therapy not medically necessary. It only solicits a Yes/No response to whether the beneficiary is being treated for a parasitic infection and requires the prescriber’s attestation and signature; no additional medical necessity criteria or disqualifying conditions are listed on the form.
Provider Actions & Form Requirements
Required form fields
A completed prior authorization form is required and must include all mandatory prescriber and beneficiary details, the requested drug information, and the selected therapy length. Incomplete forms may delay or invalidate the request.
- Beneficiary name, ID number, date of birth, and gender
- Prescribing provider NPI and requester contact phone number
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.